MARKER THERAPEUTICS, INC. (NASDAQ: MRKR) Files An 8-K Financial Statements and ExhibitsItem 9.01. Financial Statements and Exhibits.
(d) Exhibits.
ExhibitNo. | Description |
99.1 | Press release issued on November 27, 2018. |
Marker Therapeutics, Inc. ExhibitEX-99.1 2 tv507922_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Marker Therapeutics,…To view the full exhibit click here